Zymtronix and Ginkgo Bioworks announced a partnership to optimize enzymes used in Zymtronix’s proprietary cell-free platform for the production of important ingredients in food, agriculture, cosmetics and pharmaceuticals. Ginkgo Enzyme Services offers partners end-to-end support for the discovery, optimization, and production of enzymes for diverse applications. Through the partnership, Ginkgo will leverage its suite of enzyme services to engineer enzymes for Zymtronix’s applications using metagenomic enzyme discovery as well as improve enzyme expression and production host performance.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on DNA:
- Ginkgo Bioworks to lead pathogen monitoring program at Kigali Airport, Rwanda
- Cathie Wood Gets Back on Track; Here Are 2 Stocks She’s Snapping Up
- Ginkgo Bioworks and NAMUH announce collaboration to develop HMOs
- Ginkgo Bioworks, Xwell expand support for CDC’s Genomic Surveillance program
- Ginkgo Bioworks and Xwell partner in influenza variant detection for CDC
